Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.

Sponsor
Paul Saenger (Other)
Overall Status
Unknown status
CT.gov ID
NCT01326663
Collaborator
(none)
50
1
2
50
1

Study Details

Study Description

Brief Summary

Despite the body's natural healing during the first year after a head injury, many veterans who have suffered even mild brain injuries find themselves easily upset or fearful as they go about their daily lives. While these reactions to the world around them were easily managed before the head injury, they now occur with little or no interruption and are exceedingly difficult to manage. Such reactions include a sense of always being upset or fearful that often makes it difficult to get along with family members, friends, coworkers, and employers. This may lead to broken marriages, unemployment, and even homelessness.

Some people with head injuries try to manage their unmanageable moods by drinking alcohol because it can create a sense of calm. However, alcohol's actions are short in duration. Most find that they have to drink more and more for a similar calming effect, and they soon become dependent on alcohol. This makes working and being part of their families even more difficult.

To treat the unmanageable mood, we tried a medicine called valproate, one that eases mood problems in people without head injury. We gave valproate to head injured persons with mood problems in a "non-blinded" study where both the doctor and the patient knew that the medicine was valproate and both were optimistic that it would work. In a small sample of eighteen people, 85% found mood relief and most of those either stopped drinking alcohol or drank much less than before. However, this might have been because both the doctor and patient were hopeful that the medication would make the patient feel better or because the medicine actually worked.

The only way to know for sure if the medicine works is to perform a study in which people receive either valproate or a sugar pill while neither they nor their doctor know which one they are taking. This is called a double blind study, as proposed here, and will involve nearly three times as many head injured persons as the first study.

If it is successful, this study will show that valproate treatment helps head injured people manage their moods and allows them to return to families, friends, and work. It will also show that they drink alcohol less or not at all, improving their health even further. Then doctors will know that they can use this medicine for large numbers of people who suffer from head injury and help them to lead normal lives. If the outcome of the study shows that the medicine works well, doctors can then use this medicine to treat people with head injury immediately after the study results are published.

Condition or Disease Intervention/Treatment Phase
  • Drug: Medication Trial
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Study Start Date :
Oct 1, 2009
Anticipated Primary Completion Date :
May 1, 2013
Anticipated Study Completion Date :
Dec 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: divalproex sodium

Drug: Medication Trial

Placebo Comparator: sugar pill

Drug: Medication Trial

Outcome Measures

Primary Outcome Measures

  1. Reduced Affective Lability [Study weeks 1-10]

    The primary analysis addresses our primary hypothesis that treatment with divalproex sodium will lessen affective lability significantly (p<0.05) as compared to placebo. We will characterize affective lability using discrete variables of presence or extent of symptoms yielded by the Neurobehavioral Rating Scale-Revised (Levin et al., 1990) as well as eight target items from the Agitated Behavior Scale (Bogner et al., 2000). Average intensity and duration of affective lability will be compared between groups.

Secondary Outcome Measures

  1. Reduced Alcohol Use [Study weeks 1-10]

    The secondary analysis first addresses our secondary hypothesis that treatment with divalproex sodium will lessen quantity and frequency of ethanol use significantly (p<0.05) as compared to placebo in a sample of TBI subjects. We will characterize drinking using the Time Line Follow-Back for Drugs and Alcohol method, developed by Sobell et al (Sobell et al., 1979).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • a history of remote (≥ 1 year prior to study enrollment) non-penetrating TBI

  • currently using alcohol

  • symptoms of affective lability: mood swings, irritability, frustration

Exclusion Criteria:
  • a history of bipolar disorder or anxiety disorder prior to any head injury

  • a history of head injury in which the cranium was opened either traumatically or surgically

  • a history of stroke

  • a history of seizure disorder other than those caused by ethanol withdrawal

  • evidence of active liver disease

  • current diagnosis or past history of major psychosis, the alcohol amnesic syndrome, or any type of dementia

  • current suicidal/homicidal ideations

  • any medical conditions that would constitute contraindications to treatment with divalproex sodium

  • currently taking any medications that are known to affect the metabolism of divalproex sodium

Contacts and Locations

Locations

Site City State Country Postal Code
1 Denver Veteran's Affairs Medical Center Denver Colorado United States 80220

Sponsors and Collaborators

  • Paul Saenger

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Paul Saenger, Executive Director, Denver Research Institute
ClinicalTrials.gov Identifier:
NCT01326663
Other Study ID Numbers:
  • PT075168
First Posted:
Mar 31, 2011
Last Update Posted:
Sep 7, 2012
Last Verified:
Sep 1, 2012
Keywords provided by Paul Saenger, Executive Director, Denver Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 7, 2012